Cadila Healthcare (Zydus) said that it has commenced the supplies of ZyCoV-D, the company’s Covid-19 vaccine to the Indian government. The first consignment of the ZyCoV-D vaccine has been delivered already from the company’s newly commissioned Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad. It can be noted that Zydus […]
Zydus (Cadila Healthcare) has secured final approval from the US Food and Drug Administration (FDA) to market Vigabatrin Tablets in the strength of 500mg. Vigabatrin Tablets is the generic version of Sabril Tablets. It is indicated in the US for the treatment of babies, aged one month to two years, having infantile spasms. The drug […]
Cadila Healthcare (Zydus Cadilla) said that it has obtained permission from the US Food and Drug Administration (FDA) to launch the phase 2(b)/3 clinical trial of saroglitazar magnesium in primary biliary cholangitis (PBC). The late-stage trial, designed to assess the efficacy and safety of saroglitazar magnesium, will have 192 patients. The participants will be randomly […]
Cadila Healthcare (Zydus Cadila) has bagged an order from the Indian government to deliver one crore doses of its ZyCoV-D Plasmid DNA Covid-19 vaccine. According to Zydus Cadila, the vaccines will be supplied at INR 265 per dose along with needle-free applicators priced at INR 93 per dose, excluding GST. The Indian pharma company said […]
Zydus Cadila (Cadila Healthcare) has dosed the first patient in the EVIDENCES-X phase 2b clinical trial of Saroglitazar Magnesium (Saroglitazar Mg) in non-alcoholic steatohepatitis (NASH). The multi-centre, randomized, double-blind, placebo-controlled trial will assess the safety and efficacy of Saroglitazar Magnesium in patients with NASH and fibrosis. The EVIDENCES-X clinical trial will randomly group 240 patients […]
Zydus Pharmaceuticals Inc, USA, a fully-owned subsidiary of Cadila Healthcare (Zydus Cadila), has signed a license and supply deal with CHEMI SpA for launching the generic version of Sanofi Aventis’s Lovenox (Enoxaparin Sodium Injection) in the US. The generic equivalent of Enoxaparin Sodium Injection has been launched in seven dosage strengths. Enoxaparin Sodium Injection is […]
KPI Global Infrastructure said that it has commissioned a new capacity of 2.05MW at its existing solar power plant in Bharuch district in Gujarat. The solar power project is located in the Sudi and Tancha villages in Ta-Amod. According to KPI Global Infrastructure, the additional capacity was commissioned under the independent power producer (IPP) category […]
Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine for Covid-19 for adults and also adolescents in the age group of 12-18 years. According to Zydus Cadila, ZyCoV-D is the first Plasmid DNA vaccine for Covid-19 in the world. […]
Cadila Healthcare said that it has completed its previously announced sale of Zydus Animal Health and Investments to Zenex Animal Health India (formerly Nutrizvit Animal Health India). The consideration of the deal announced in May 2021 is INR 2,921 crores. Zydus Animal Health and Investments has been one of the key players in the Indian […]
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Pemetrexed for Injection in 100mg/vial, 500mg/vial, and 1000mg/vial, single-dose vials. Pemetrexed for Injection is the generic for Eli Lilly and Company (Lilly) owned Pemetrexed, which is sold under Alimta and other […]